IP Library › Granted Patent US 8,889,375
Granted Patent B2
US 8,889,375 · App. 13/258,064 · Granted Nov 18, 2014

Hypoglycemic effect enhancer

Inventors: Yasuhiro Isa (Hyogo, JP); Masaki Shimakawa (Hyogo, JP); Hiroshi Ohno (Hyogo, JP); Hideki Yamamura (Hyogo, JP)
Assignee: Biofermin Pharmaceutical Co., Ltd.
A61K31/133A23L2/02A61K35/742A23Y2300/00A23Y2240/33A61K45/06C07C215/44A23V2002/00A23Y2300/25A61K35/744A23L1/0345C07D211/46A23L1/3014A61K31/702A61K35/747A61K31/445
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,375
App. No.
13/258,064
Granted
Nov 18, 2014
Kind
B2
Abstract

A hypoglycemic effect enhancer for enhancing the activity of an α-glucosidase inhibitor, the enhancer comprising at least one kind of bacteria selected from the group consisting of bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria.

Claims (3)

1. A method for enhancing the hypoglycemic activity of voglibose, the method comprising administering to a patient in need thereof lactic acid bacteria, and saccharifying bacteria or bifidobacteria in combination with voglibose, and enhancing the hypoglycemic activity of voglibose.

2. A method for enhancing the hypoglycemic activity of lactic acid bacteria, and saccharifying bacteria or bifidobacteria, the method comprising administering to a patient in need thereof voglibose in combination with the bacteria, and enhancing the hypoglycemic activity of the bacteria.

3. A method for promoting the expression of the hypoglycemic activity of voglibose, the method comprising administering to a patient in need thereof lactic acid bacteria, and saccharifying bacteria or bifidobacteria in combination with voglibose, and promoting the expression of the hypoglycemic activity of voglibose.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2011
From: ISA, YASUHIRO; SHIMAKAWA, MASAKI; OHNO, HIROSHI; YAMAMURA, HIDEKI
To: BIOFERMIN PHARMACEUTICAL CO., LTD.
Reel/Frame 026980/0759 →
Priority Claims (1)
JP 2009-077555 · Mar 26, 2009 · national
Continuity (1)
Related Publication 20120014923A1 · Jan 19, 2012